Stock listing

Dusseldorf:OL0 Devyser Diagnostics AB Aktie

German listing (Dusseldorf) of Devyser Diagnostics AB · home listing Stockholm:DVYSR

Follow Devyser Diagnostics AB into a list and get an email when it puts out news.

Home listing price · OMXSTO:DVYSR

60.00 SEK -2.80 (-4.5%)

Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, OMXSTO:DVYSR

Past year -44.6% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
59.00 – 62.50 SEKNov 20, 2026
Volume
24,844 sharesNov 20, 2026
Market cap
1.01B SEKAt the close on Nov 20, 2026 · price × 16.89M shares outstanding
52-week range
48.50 – 120.00 SEKLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
1.09M SEKMedian day 13,654 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Devyser Diagnostics AB logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
Stockholm:DVYSR · Home60.00 SEK-2.80 (-4.5%)24,84462.3062.5059.0062.80Close on Nov 20, 2026
Frankfurt:OL0€5.24 EUR-0.36 (-6.4%)—€5.55€5.55€5.24€5.60Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · OMXSTO:DVYSR · SEK, adjusted for splits

DayCloseChange%OpenHighLowVolume
60.00-2.80-4.5%62.3062.5059.0024,844
62.80-0.30-0.5%63.0064.7061.508,861
63.10-1.40-2.2%63.3064.5063.1010,754
64.50-1.10-1.7%66.4066.4064.1013,115
65.60+0.60+0.9%65.1067.7065.104,823
65.00-1.70-2.5%66.8067.9065.005,625
66.70+1.90+2.9%65.0068.6064.0033,377
64.80-2.80-4.1%68.4068.4063.9024,044
67.60+3.30+5.1%65.3068.7064.4037,401
64.30-0.50-0.8%65.2065.9063.0021,997
64.80+3.30+5.4%65.1068.0062.0072,273
61.50+6.50+11.8%55.9063.0055.9057,172
55.00-3.00-5.2%58.0058.0055.0010,643
58.00-1.50-2.5%59.4059.4058.0061,174
59.50+4.50+8.2%56.5059.8056.4024,045
55.00+4.60+9.1%51.1055.0049.8052,265
50.40-0.60-1.2%50.1051.4050.0014,472
51.00+1.00+2.0%50.1051.3050.1010,359
50.00-0.50-1.0%50.1050.8049.608,742
50.500.000.0%50.6053.1049.9028,473
50.50-0.50-1.0%50.6051.1049.708,556
51.00+1.00+2.0%50.0051.1049.5010,048
50.00-0.40-0.8%50.8051.6049.858,091
50.40-0.10-0.2%50.5050.5048.5019,679
50.50-0.30-0.6%51.3052.0050.0015,952
50.80+1.05+2.1%50.5051.3050.0021,150
49.75-1.05-2.1%50.5050.8049.7515,458
50.80-0.30-0.6%51.8052.1050.2018,324
51.10-1.50-2.9%52.1052.1051.1016,472
52.60-0.90-1.7%53.1053.5052.109,387
53.50-0.50-0.9%54.6055.5052.4064,621
54.00-0.80-1.5%55.0056.4052.3033,955
54.80+3.70+7.2%51.2055.6051.0023,522
51.10+0.30+0.6%50.8051.5050.6045,213
50.80+0.30+0.6%50.8050.9050.2028,554
50.50-0.60-1.2%51.1051.2050.1050,666
51.10-0.60-1.2%51.7051.7050.708,979
51.70-0.60-1.1%53.7053.7051.206,009
52.30-0.70-1.3%53.0053.0051.703,355
53.00+0.20+0.4%53.0053.5052.2010,360
52.80-0.10-0.2%52.9053.3052.206,190
52.90-0.60-1.1%53.5054.0052.3016,915
53.50-1.30-2.4%54.8056.8052.9013,772
54.80-0.20-0.4%55.0055.0052.9013,069
55.00+1.00+1.9%53.7055.0053.604,445
54.00-0.90-1.6%54.7054.7053.0027,913
54.90-0.80-1.4%56.5056.5054.508,966
55.70-1.10-1.9%56.8056.8055.209,424
56.80-2.00-3.4%59.9059.9056.2015,432
58.80-1.20-2.0%59.1059.7058.803,752
60.00+0.40+0.7%60.4060.4058.704,696
59.60-0.30-0.5%61.1061.1059.003,066
59.90+0.30+0.5%60.4060.4059.0010,905
59.60-0.10-0.2%59.9060.2059.306,118
59.70+1.20+2.1%58.9059.9058.0025,748
58.50-0.10-0.2%59.4059.4058.108,015
58.60-0.30-0.5%59.0059.6058.3015,352
58.90-1.10-1.8%59.3060.4058.808,483
60.00+0.30+0.5%59.6060.7059.2020,243
59.700.000.0%60.0060.0058.9010,851
59.70+0.10+0.2%59.2060.0059.0010,829
59.60-0.20-0.3%59.5062.1058.7013,535
59.80-1.30-2.1%61.2062.2059.6022,560
61.10+0.90+1.5%65.7065.7060.306,980
Ticker
Dusseldorf:OL0
Asset type
Stock
Sector
Health care
Industry
Diagnostics & research services
Exchange
Dusseldorf
Currency
EUR

What changed lately

Latest news

All Devyser Diagnostics AB news

Devyser Diagnostics AB on 6ix

Sector
Health care
Industry
Diagnostics & research services
News releases
6 in the last 12 months · 10 in all · newest Apr 27, 2026 · oldest 2025
Calls
10 calls with a replay · 10 with a transcript · latest Jul 20, 2026
Decks
13 decks · latest Nov 3, 2026

Where Devyser Diagnostics AB is listed

ListingExchangeCountryCurrency
Stockholm:DVYSR · Home listingStockholmSwedenSEK
LS Exchange:A3C811LS ExchangeGermanyEUR
gettex:OL0gettexGermanyEUR
Lang & Schwarz:A3C811Lang & SchwarzGermanyEUR
Munich:OL0MunichGermanyEUR
Frankfurt:OL0FrankfurtGermanyEUR
Stuttgart:OL0StuttgartGermanyEUR
Dusseldorf:OL0 · This pageDusseldorfGermanyEUR
OTC:DVYSFOTCUnited StatesUSD

Valuation

P/E 39.9× against a median of 25.0×: 4th lowest of 6 Diagnostics & research services companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026

Enterprise value
968.7M SEK
P/E
39.9×
EV/sales
3.8×
EV/EBITDA
17.5×
Price/book
2.6×
Gross margin
80.1%
Operating margin
11.0%
Net margin
10.0%
Debt to equity
0.1×
Beta
No index for this market yet

Diagnostics & research services: the 10 companies nearest in size, of 302 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Devyser Diagnostics AB · OMXSTO:DVYSRUS$99.24MUS$94.86M39.9×3.8×17.5×2.6×10.0%0.1×n/a
Burning Rock Biotech Ltd. · NASDAQ:BNRUS$116.7MUS$60.54Mn/a0.8×n/a1.6×−13.6%0.1×1.51
BIODYNE Co., Ltd. · KRX:314930US$115.0MUS$104.0M182×19.9×70.7×3.5×12.1%0.0×n/a
Photocure ASA · OSL:PHOUS$113.9MUS$97.23M22.9×1.4×6.1×1.9×7.1%0.0×n/a
ArcticZymes Technologies ASA · OSL:AZTUS$108.4MUS$80.84M66.1×6.2×24.6×3.0×12.7%0.0×n/a
NanoenTek, Inc. · KRX:039860US$107.8MUS$71.26M24.8×2.2×17.4×1.5×13.3%0.0×n/a
BICO Group AB Class B · OMXSTO:BICOUS$102.7MUS$90.50Mn/a0.6×2.1×0.8×−28.3%0.3×n/a
Quanterix Corporation · NASDAQ:QTRXUS$93.06MUS$47.06Mn/a0.3×n/a0.4×−75.0%0.1×1.87
Exagen Inc. · NASDAQ:XGNUS$92.10MUS$86.82Mn/a1.2×n/a6.7×−25.1%1.7×2.52
Biodesix, Inc. · NASDAQ:BDSXUS$83.83MUS$105.4Mn/a1.0×n/a9.7×−25.7%5.8×1.56
Bonraybio Co. Ltd. · TWSE:6955US$81.85MUS$65.60M25.0×6.5×18.1×4.1×32.5%0.0×n/a
Median of the othersUS$105.3MUS$83.83M25.0×1.3×17.8×2.5×−3.3%0.1×1.72

Forecasts

Analysts' consensus from EODHD, read Nov 11, 2026. Not 6ix's view and not investment advice.

Price target
100.17 SEK · Analysts' mean
EPS, year to Dec 2026
0.73 · 2 analysts
Revenue, year to Dec 2026
247.1M · 2 analysts

Team and board

Officers

OfficerRole
Jan WahlströmCEO
Niklas AxelssonCFO
Sabina BerlinVP IR & Corporate Affairs
Olle MyrbergVP Quality & Regulatory Affairs
Robin SortebechVP Supply Chain
Michael UhlinCSO

Board

DirectorRole
Mia ArnhultChairman
Fredrik DahlBoard member
Olof EricssonBoard member
Pia GideonBoard member
Thomas EklundBoard member

Events

Next results
Feb 16, 2027 (expected)

Results days

QuarterResultsShare move
Q3 2026Nov 3, 2026 · Before open+5.4%
Q2 2026Jul 19, 2026 · After close0.0%
Q1 2026Apr 27, 2026 · Before open+7.2%
Q4 2025Feb 11, 2026 · After close+3.5%
Q3 2025Nov 4, 2025 · After close−9.8%
Q2 2025Jul 22, 2025 · Before open+9.8%
Q1 2025Apr 29, 2025 · Before open−0.5%
Q4 2024Feb 13, 2025 · Before open−7.2%
Q3 2024Oct 30, 2024 · Before open−1.5%
Q2 2024Jul 23, 2024 · Before open−0.9%
All 20 quarters
QuarterResultsShare move
Q1 2024May 8, 2024 · Before open+5.8%
Q4 2023Feb 19, 2024 · After close+7.2%
Q3 2023Nov 9, 2023 · Before open+3.1%
Q2 2023Aug 23, 2023 · Before open−1.0%
Q1 2023May 9, 2023 · Before open−2.8%
Q4 2022Feb 21, 2023 · Before open+1.5%
Q3 2022Nov 10, 2022 · Before open−1.5%
Q2 2022Aug 24, 2022 · Before open−0.2%
Q1 2022May 11, 2022 · Before open−0.7%
Q4 2021Feb 24, 2022 · Before open−2.2%

Open Events

Decks

DeckKindSlidesDate
Q3 2026 Earnings PresentationEarnings22 slidesNov 3, 2026
Q2 2026 Earnings PresentationEarnings23 slidesJul 20, 2026
Q1 2026 Earnings PresentationEarnings23 slidesApr 27, 2026
Q4 2025 Earnings PresentationEarnings27 slidesFeb 12, 2026
Q3 2025 Earnings PresentationEarnings24 slidesNov 5, 2025
Q2 2025 Earnings PresentationEarnings23 slidesJul 22, 2025
Q1 2025 Earnings PresentationEarnings24 slidesApr 29, 2025
Investor Day (November 2024)Investor day76 slidesNov 25, 2024
Q3 2024 Earnings PresentationEarnings21 slidesOct 30, 2024
Q2 2024 Earnings PresentationEarnings21 slidesJul 23, 2024
All 13 decks
DeckKindSlidesDate
Q1 2024 Earnings PresentationEarnings26 slidesMay 8, 2024
Devyser — Q2 2023 Earnings PresentationEarnings21 slidesAug 23, 2023
Q1 2023 Earnings PresentationEarnings18 slidesMay 9, 2023

Open Decks

Financials

Annual, in SEK

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Revenue250.5M216.9M169.3M126.6M93.5M65.7M64.3M48.1M
Cost of revenue48.6M44.2M21.2M20.8M18.8M9.04M12.0M13.3M
Gross profit201.9M172.7M148.1M105.8M74.7M56.6M52.3M34.8M
Research and development18.0M43.1M41.1M28.6M20.8M21.7M9.90M8.62M
Selling, general and administrative56.0M51.3M42.0M37.9M28.8M11.7M
Operating income10.6M-58.3M-56.5M-54.9M-21.8M-6.96M8.65M-3.51M
Depreciation and amortization27.1M27.7M9.80M6.16M3.28M2.96M2.32M1.25M
EBITDA37.7M-30.6M-46.7M-48.8M-18.5M-3.99M11.0M-2.27M
Interest expense13.6M3.50M800.0K500.0K939.0K925.0K785.0K596.0K
Income before tax-2.60M-57.6M-54.4M-52.7M-22.3M-10.9M10.2M-232.0K
Income tax5.80M3.90M-800.0K-6.80M-1.18M-985.0K2.62M-751.0K
Net income-8.40M-61.5M-53.6M-46.0M-20.7M-10.9M7.01M519.0K
Earnings per share, basic-0.51-3.75-3.31-2.89-1.85-3.762.310.17

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Cash and equivalents77.5M144.5M262.9M363.6M377.6M8.34M10.4M7.54M
Short-term investments-1
Receivables67.0M74.6M45.3M33.4M26.2M25.1M17.2M15.3M
Inventory37.0M30.2M20.6M10.3M6.95M5.45M3.87M4.13M
Current assets204.3M252.3M341.8M412.1M412.7M39.7M32.4M27.8M
Goodwill6.60M7.00M6.70M6.77M236.0K236.0K
Total assets469.7M473.8M510.1M500.6M456.9M74.4M73.7M48.2M
Accounts payable17.9M12.6M14.2M9.60M9.66M6.34M3.40M3.17M
Current liabilities70.9M72.6M62.9M51.2M29.4M28.0M15.9M9.75M
Long-term debt300.0K300.0K600.0K600.0K04.22M
Total debt51.9M59.1M74.8M21.2M13.0M21.5M23.9M9.72M
Total liabilities115.4M124.8M125.0M69.2M40.2M43.6M36.7M18.3M
Shareholders' equity354.3M349.1M385.1M431.4M416.7M30.8M37.0M30.0M
Shares outstanding16.6M16.4M16.2M15.9M11.2M2.90M3.03M3.00M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Cash from operations8.20M-46.8M-69.7M-40.5M-16.5M627.0K14.6M6.02M
Capital spending-1.50M-76.9M-32.0M-25.8M-8.80M-3.41M-9.31M-5.06M
Free cash flow6.70M-123.7M-101.7M-66.3M-25.3M-2.79M5.32M957.0K
Cash from investing-70.7M-76.9M-32.0M-23.9M-10.3M-4.71M-9.96M-5.06M
Cash from financing-2.80M7.80M-200.0K48.9M395.9M2.27M-1.87M-974.0K
Change in cash-67.0M-118.4M-100.7M-14.0M369.3M-2.04M2.84M-17.0K

Open Financials

Cap table

Built by 6ix from Devyser Diagnostics AB’s releases

Common shares
16,889,806
Fully diluted
16,889,806

Fully diluted

LineShares
Common shares16,889,806

Share count over time

CountShares
Nov 22, 202616,889,806

Open Cap table

Shareholders

Funds

HolderSharesValueChangeAs of
Polar Capital International Small Company Fund202KUS$1.79M−3,280Jun 30, 2026

Insider trades

InsiderTradeSharesPriceValueDate
M2 Asset Management AB
Closely associated with Mia Arnhult (Chairman of the Board of Directors)
Buy2,000SEK 64.90SEK 130KNov 9, 2026
Jan Wahlström
Chief Executive Officer (CEO)/Managing Directory
Buy1,000SEK 54.04SEK 54,045Sep 15, 2026
M2 Asset Management AB
Closely associated with Mia Arnhult (Chairman of the Board of Directors)
Buy2,000SEK 60.00SEK 120KSep 3, 2026
M2 Asset Management AB
Closely associated with Mia Arnhult (Chairman of the Board of Directors)
Buy568SEK 59.50SEK 33,796Aug 25, 2026
M2 Asset Management AB
Closely associated with Mia Arnhult (Chairman of the Board of Directors)
Buy5,000SEK 63.01SEK 315KAug 11, 2026
M2 Asset Management AB
Closely associated with Mia Arnhult (Chairman of the Board of Directors)
Buy250SEK 65.80SEK 16,450Aug 4, 2026
M2 Asset Management AB
Closely associated with Mia Arnhult (Chairman of the Board of Directors)
Buy2,533SEK 65.40SEK 166KJul 31, 2026
M2 Asset Management AB
Closely associated with Mia Arnhult (Chairman of the Board of Directors)
Buy7,944SEK 66.98SEK 532KJul 28, 2026
M2 Asset Management AB
Closely associated with Mia Arnhult (Chairman of the Board of Directors)
Buy14,364SEK 64.62SEK 928KJul 27, 2026
M2 Asset Management AB
Closely associated with Mia Arnhult (Member of the Board of Directors)
Buy1,545SEK 61.64SEK 95,234Jul 24, 2026
All 21 trades
InsiderTradeSharesPriceValueDate
Mia Arnhult
Chairman of the Board of Directors
Buy2,000SEK 62.40SEK 125KJul 24, 2026
Mia Arnhult
Chairman of the Board of Directors
Buy1,500SEK 61.80SEK 92,700Jul 24, 2026
Jan Wahlström
Chief Executive Officer (CEO)/Managing Directory
Buy2,000SEK 66.09SEK 132KJul 20, 2026
Jan Wahlström
Chief Executive Officer (CEO)/Managing Directory
Buy3,000SEK 66.28SEK 199KJul 20, 2026
Jan Wahlström
Chief Executive Officer (CEO)/Managing Directory
Buy1,000SEK 96.51SEK 96,514May 22, 2026
Jan Wahlström
Chief Executive Officer (CEO)/Managing Directory
Buy2,000SEK 94.90SEK 190KMay 21, 2026
Jan Wahlström
Chief Executive Officer (CEO)/Managing Directory
Buy45SEK 92.90SEK 4,181May 20, 2026
Mia Arnhult
Chairman of the Board of Directors
Buy500SEK 77.00SEK 38,500Mar 20, 2026
Mia Arnhult
Chairman of the Board of Directors
Buy500SEK 79.40SEK 39,700Mar 18, 2026
Mia Arnhult
Chairman of the Board of Directors
Buy500SEK 79.26SEK 39,630Mar 18, 2026
Jan Wahlström
Chief Executive Officer (CEO)/Managing Directory
Buy3,000SEK 100.59SEK 302KFeb 18, 2026

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Fredrik DahlBoard member · Since at least Jul 22, 2025
Jan WahlströmCEO · Since at least Apr 27, 2026
Mia ArnhultChairman · Since at least Jul 22, 2025
Michael UhlinCSO · Since at least Apr 29, 2025
Niklas AxelssonCFO · Since at least Nov 4, 2026
Olle MyrbergVP Quality & Regulatory Affairs · Since at least Apr 29, 2025
Olof EricssonBoard member · Since at least Jul 22, 2025
Pia GideonBoard member · Since at least Jul 22, 2025
Robin SortebechVP Supply Chain · Since at least Apr 29, 2025
Sabina BerlinVP IR & Corporate Affairs · Since at least Apr 27, 2026
All 11 people
PersonSeat
Thomas EklundBoard member · Since at least Jul 22, 2025

Open People

Log in to ask 6ix AI your own questions about Devyser Diagnostics AB.